Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca 2+ does not activate tumor proliferation

Journal of Molecular Neuroscience

Volumn 22, Issue 1-2, 2004, Pages 83-91

  Germano, Patrizia M ^a   Le, Sang V ^a   Oh, David S ^a   Fan, Robert ^a   Lieu, Sandy ^a   Siu, Alan ^a   Pisegna, Joseph R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenylyl cyclase; Pituitary adenylate cyclase activating polypeptide; Pituitary adenylate cyclase activating polypeptide type 1 receptor

Indexed keywords

CALCIUM ION; CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; ADCYAP1 PROTEIN, HUMAN; ADCYAP1R1 PROTEIN, HUMAN; ADENYLATE CYCLASE; CALCIUM; HORMONE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; ISOPROTEIN; NEUROPEPTIDE;

CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CANCER; COLON TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; ALTERNATIVE RNA SPLICING; ARTICLE; CALCIUM SIGNALING; CANCER INVASION; CARCINOMA; CELL DIVISION; COMPARATIVE STUDY; GENETICS; INTRACELLULAR FLUID; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENYLATE CYCLASE; ALTERNATIVE SPLICING; CALCIUM; CALCIUM SIGNALING; CARCINOMA; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIC AMP; HUMANS; INTRACELLULAR FLUID; NEOPLASM INVASIVENESS; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN ISOFORMS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE;

EID: 3042782802     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:22:1-2:83     Document Type: Conference Paper

References (17)

1. Deutsch P. J. and Sun Y. (1992) The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J. Biol. Chem. 267, 5108-5113.
2. Germano P. M., Stalter J., Le S. V., Wu M., Yamaguchi D. J., Scott D., and Pisegna J. R. (2001) Characterization of the pharmacology, signal transduction and internalization of the fluorescent PACAP ligand, fluor-PACAP, on NIH / 3T3 cells expressing PAC1. Peptides 22, 861-866.
3. Harmar A. J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J. R., et al. (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50, 265-270.
4. Hoshino M., Li M., Zheng L. Q., Suzuki M., Mochizuki T., and Yanaihara N. (1993) Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells. Neurosci Lett. 159, 35-38.
5. Le S. V., Yamaguchi D. J., McArdle C. A., Tachiki K, Pisegna J. R., and Germano P. (2002) PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells. Regul. Pept. 109, 115-125.
6. Lyu R., Germano P. M., Choi J. K., Le S. V., and Pisegna J. R. (2000) Identification of an essential amino acid motif within the C-terminus of the pituitary adenylate cyclase-activating polypeptide type 1 receptor that is critical for signal truncation but not for receptor internalization. J. Biol. Chem. 275, 36134-36142.
7. Miampamba M., Germano P. M., Arli S., Wong H. H., Scott D., Tache Y., and Pisegna J. R. (2002) Expression of pituitary adeylate cyclase-activating 16 polypeptide and PACAP type I receptor in the rat gastric and colonic myenteric neurons. Regul.Pept. 105, 145-154.
8. Miyata A., Jiang L., Dahl R. R., Kitada C., Kubo K., Fujino M., et al. (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP-38). Biochem. Biophys. Res. Commun. 170, 643-648.
9. Moody T. W., Leyton J., Casibang M., Pisegna J. R., and Jensen R. T. (2002) PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Regul. Pept. 109, 135-140.
10. Moody T. W., Zia F., and Makheja A. (1993) Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells. Peptides 14, 241-246.
11. Pisegna J. R. and Wank S. A. (1996) Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor: evidence for dual coupling to adenylate cyclase and phospholipase C. J. Biol. Chem. 271, 17267-17271.
12. Pisegna J. R, Leyton J., Coelho T., Hida T., Jakolew S., Birrer S., et al. (1997) Differential activation of immediate-early gene expression by four splice variants of the human pituitary activating polypeptide receptor: evidence for an activation by PACAP hybrid and the phospholipase C inhibitor U73122. Life Sci. 61, 631-639.
13. Robberecht P., Woussen-Colle M. C., De Neef P., Gourlet P., Buscail L., Vandermeers A., et al. (1991) The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP [1-27] 17 and PACAP [1-38]) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes. FEBS Lett. 286, 133-136.
14. Salomon Y., Londos C., and Rodbell M. (1974) A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541-548.
15. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P. H., and Journot L. (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365, 170-175.
16. Zeng N., Rang T., Wong H., Walsh J. H., Sachs G. A., and Pisegna J. R. (1999) PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J. Clin. Invest. 104, 1383-1391.
17. Zia F., Fagarasan M., Bitar K., Coy D. H., Pisegna J. R., Wank S. A., and Moody, T. W. (1996) PACAP receptors regulate the growth of non-small cell lung cancer cells. Cancer Res. 55, 4886-4891.